Skip to content

Infection among pregnant women

A prospective cohort study to apprise the prevalence of congenital infections and genetic abnormalities of fetus: Acquaint to prevent the congenital anomalies.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050820
Enrollment
135
Registered
2023-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P369- Bacterial sepsis of newborn, unspecified Health Condition 2: P351- Congenital cytomegalovirus infection Health Condition 3: P352- Congenital herpesviral [herpes simplex] infection Health Condition 4: P379- Congenital infectious or parasiticdisease, unspecified Health Condition 5: P350- Congenital rubella syndrome Health Condition 6: P371- Congenital toxoplasmosis Health Condition 7: P359- Congenital viral disease, unspecified Health Condition 8: P353- Congenital viral h

Interventions

None listed

Sponsors

Department of Health Research
Lead Sponsor
Manipal Academy of Higher Education
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Stillbirth/ Intrauterine death Premature rupture of membrane (PROM) Preterm delivery Early onset Foetal growth restriction (FGR) Unexplained early Oligoamnios Uteroplacental insufficiency as evidenced by abnormal Dopplerâ??s (early onset) CNS findings Ventriculomegaly Intracranial calcification Echogenic Bowel loops Third-space fluid collections Pleural effusion Hydrops fetalis Hepatosplenomegaly Fetal anaemia Calcification in liver

Exclusion criteria

Exclusion criteria: Pregnant woman with a previously established genetic abnormality. Non-consent individuals

Design outcomes

Primary

MeasureTime frame
Find prevalence of pathogens causing congenital infections and their clinical outcomes List of rare and common pathogens and their outcome in terms of fetal death or anomalies The finding of epidemiological, demographical and clinical, laboratory, and biomarkers associated with congenital infection and disease progressionTimepoint: 32 weeks in case of pre-partum 12 weeks in case of post-partum

Secondary

MeasureTime frame
Obtained data will be useful in the policy-making in future Improved clinical suspicion among physicians leading to better patient outcomes Information on sequelae of congenital infection and comparative analysis of sequelae upon infection of different pathogens Derive mitigation strategy for congenital infectionsTimepoint: 32 weeks in case of pre-partum 12 weeks in case of post-partum

Countries

India

Contacts

Public ContactDr Chiranjay Mukhopadhyay

Manipal Institute of Virology

chiranjay.m@manipal.edu9845513057

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026